About Baqiyatallah Research Center for Gastroenterology and Liver Diseases
Clinical Trials at Baqiyatallah Research Center for Gastroenterology and Liver Diseases
During the past decade, Baqiyatallah Research Center for Gastroenterology and Liver Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Baqiyatallah Research Center for Gastroenterology and Liver Diseases"
#1 collaborator was "Baqiyatallah Research Center for Gastroenterology and Liver Diseases" with 2 trials as a collaborator, "Guilan University of Medical Sciences" with 2 trials as a collaborator, "Tabriz Research Center for Gastroenterology and Liver Diseases" with 2 trials as a collaborator, "Tehran Hepatitis Center" with 2 trials as a collaborator and "Iran University of Medical Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Baqiyatallah Research Center for Gastroenterology and Liver Diseases
According to Clinical.Site data, the most researched conditions in "Baqiyatallah Research Center for Gastroenterology and Liver Diseases" are
"Hepatitis C" (2 trials), "Hemophilia" (1 trials) and "Thalassemia" (1 trials). Many other conditions were trialed in "Baqiyatallah Research Center for Gastroenterology and Liver Diseases" in a lesser frequency.
Clinical Trials Intervention Types at Baqiyatallah Research Center for Gastroenterology and Liver Diseases
Most popular intervention types in "Baqiyatallah Research Center for Gastroenterology and Liver Diseases" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Baqiyatallah Research Center for Gastroenterology and Liver Diseases
The vast majority of trials in "Baqiyatallah Research Center for Gastroenterology and Liver Diseases" are
2 trials for "All" genders.
Clinical Trials Status at Baqiyatallah Research Center for Gastroenterology and Liver Diseases
Currently, there are NaN active trials in "Baqiyatallah Research Center for Gastroenterology and Liver Diseases".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Baqiyatallah Research Center for Gastroenterology and Liver Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Baqiyatallah Research Center for Gastroenterology and Liver Diseases, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".